Executive Summary
M/S. Simpson & Company Limited appealed a judgment that had dismissed its suit against Shri Rhythm Agarwal for trademark infringement and passing off related to 'Radisson' paints. The lower court held that the High Court lacked jurisdiction because the cause of action did not arise wholly within its territorial limits, despite the appellant having a branch office in Uttar Pradesh. The Division Bench overturned this decision, asserting that Section 134(2) allows filing where the principal place of business is situated, and holding that the court had sufficient jurisdiction to proceed with the suit.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Madras High Court. Understanding the court's reasoning in M/S. Simpson & Company Limited vs Shri Rhythm Agarwal is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
M/s.R.K.Ganapathi ChettiarvsKothai Dairy Farm
M/s.R.K.Ganapathi Chettiar filed a suit against Kothai Dairy Farm and others alleging infringement of their trademarks and copyrights related to the product 'ghee'. The plaintiff sought permanent injunctions, damages, and rendition of accounts due to alleged passing off and unauthorized use of artistic works and trade dress. Ultimately, the parties reached a Joint Compromise Memo on 21.03.2022, which was subsequently decreed by the Madras High Court.
Mankind Pharma LimitedvsMotherkind Pharma Private Limited
The Delhi High Court granted an interim injunction favoring Mankind Pharma Limited against Motherkind Pharma Private Limited. The court found that Motherkind's use of 'MOTHERKIND' prima facie amounted to trademark infringement and passing off, given its similarity to Mankind's well-known marks ('MANKIND' and 'KIND') in the pharmaceutical sector. This preliminary order restrains the Defendant from using the infringing mark until further proceedings.
Regeneron Pharmaceuticals, Inc.vsThe Assistant Controller of Patents and Designs, Government of India
Regeneron Pharmaceuticals appealed the rejection of its patent application (No. 592/CHENP/2012) by the Assistant Controller, which cited non-compliance with Section 59(1) of the Patents Act regarding amendments. The court found that the respondent's order was unreasoned because it failed to discuss the appellant's explanation despite having been provided. Consequently, the appeal was allowed and the matter was remitted for fresh consideration.
Malpani EnterprisesvsRegistrar Of Trade Marks
The Delhi High Court ruled in favor of Malpani Enterprises, directing the Registrar of Trade Marks to accept and proceed with its Notice of Opposition. The core issue was a technical glitch in the online filing portal which prevented the petitioner from meeting the deadline. Given that the respondent admitted the statutory period had not lapsed, the court held that a party should not suffer due to administrative or technical failures, thereby setting aside the rejection letter.
Mankind Pharma LimitedvsKindwaves Healthcare Private Limited
In a trademark infringement suit, the Delhi High Court granted several interim reliefs favoring the plaintiff, Mankind Pharma Limited. The court allowed the appointment of a Local Commissioner to conduct an inventory of all products bearing the allegedly infringing mark 'KINDWAVES' at the defendant's premises. Furthermore, recognizing the urgency of the matter, the court exempted the plaintiff from mandatory pre-institution mediation and granted exemption from advance service, allowing the suit to proceed swiftly.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.